Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) (UNAUDITED)

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 47,973 $ 190,255
Cost of revenue 32,729 159,711
Gross Profit 15,244 30,544
Operating Expenses    
Selling expense 32,848 48,980
Compensation - officers and directors 117,551 125,387
Research and development 264,797 372,258
Professional fees 385,205 472,991
General and administrative 486,554 282,455
Total Operating Expenses 1,286,955 1,302,071
Loss from Operations (1,271,711) (1,271,527)
Other Income (Expense):    
Interest income (expense), net 40,090 21,888
Unrealized loss on marketable equity securities (14,013) (2,992)
Other income (expense), net (444) 1,253
Total other income 25,633 20,149
Net loss (1,246,078) (1,251,378)
Accretion of redeemable preferred stock (226,666) 0
Net loss available to common stockholders (1,472,744) (1,251,378)
Other comprehensive items    
Foreign currency translation income (loss) 5,026 (6,368)
Total comprehensive loss $ (1,467,718) $ (1,257,746)
Net loss per share, Basic $ (1.48) $ (1.68)
Net loss per share, Diluted $ (1.48) $ (1.68)
Weighted average number of common shares outstanding, Basic 994,059 743,849
Weighted average number of common shares outstanding, Diluted 994,059 743,849